Jilin Province Tumor Hospital

Changchun, Jilin 132000

2 studies enrolling now · 3 studies all time

What they study most

Advanced or Metastatic Breast Cancer, Carcinoma, Non-Small-Cell Lung, Carcinoma, Non-Small-Cell Lung (NSCLC), Locally Advanced or Metastatic Castration-resistant Prostate Cancer, Locally Advanced or Metastatic ER+ HER2- Breast Cancer, Locally Advanced or Metastatic Non-small Cell Lung Cancer, Non-Small Cell Lung Cancer

Studies at this site

• This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1. — Recruiting now
• Study of PF-07248144 in Advanced or Metastatic Solid Tumors — Recruiting now
• A Study to Learn About the Study Medicine Called PF-07220060 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment — Running, not enrolling